Clinical Trial Update: Biomarkers in First Episode Schizophrenia

View source ↗

Summary

A completed clinical trial update focusing on biomarkers in first-episode schizophrenia, with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder Depressed Type
• Schizophrenia
• Schizophreniform Disorder

Snippet

Sponsor: NYU Langone Health | Conditions: Schizophrenia, Schizophreniform Disorder | Status: COMPLETED | Results posted: 2021-01-14